Previous 10 | Next 10 |
GT Biopharma to Present at Raymond James Human Health Innovation Conference PR Newswire BEVERLY HILLS, Calif., June 16, 2021 /PRNewswire/ -- GT Biopharma, Inc. ("GT Biopharma" or the "Company") (NASDAQ: GTBP), a clinical stage immuno-oncology company focused...
ImmunoGenesis Announces Publication of Phase 1 Data on its Hypoxia-Reversal Agent Highlighting Efficacy and Genetic Expression Correlatives in Advanced Cancer Data reported in Clinical Cancer Research support the efficacy of evofosfamide in combination with checkpoint inhibition...
Veralox Therapeutics Announces Closing Of $16.6 Million Series A Financing And Announces New Board Members PR Newswire FREDERICK, Md. , June 16, 2021 /PRNewswire/ -- Veralox Therapeutics, a biotechnology company developing first-in-class small molecule thera...
New study confirms that social determinants of health challenges are prevalent among commercially-insured populations Analysis of a large commercially-insured population shows that more than a quarter of the workforce is vulnerable to SDoH barriers to care PR Newswire ...
Cold Chain Technologies Announces Further Global Expansion Into Latin America Cold Chain Technologies Is Ready to Offer its 50 Years of Experience to the Life Sciences Industry in Latin America PR Newswire FRANKLIN, Mass. , June 16, 2021 /PRNewswire/ -- Cold ...
KAHR Announces $46.5 Million Financing to Advance its Multifunctional Immunotherapeutic Pipeline Proceeds will enable further clinical development of DSP107, a first-in-class CD47x41BB targeting fusion protein, for the treatment of solid and hematological tumors and accelerate t...
Elanco Announces Agreement to Acquire Kindred Biosciences Bolt-on Acquisition Accelerates Elanco's Expansion in Pet Health Elanco to host conference call for investment community at 8:00 am Eastern Time -- Elanco will acquire all outstanding stock of Kindred Biosciences ...
Zhongchao Inc. Partners with a Subsidiary of AbbVie Inc. (NYSE: ABBV) for Medical Education Services PR Newswire SHANGHAI , June 16, 2021 /PRNewswire/ -- Zhongchao Inc. (NASDAQ: ZCMD) ("Zhongchao" or the "Company"), a healthcare services company offering onl...
United Therapeutics Announces FDA Acceptance of Tyvaso DPI™ New Drug Application For Priority Review FDA action expected in October 2021 PR Newswire SILVER SPRING, Md. and RESEARCH TRIANGLE PARK, N.C. , June 16, 2021 /PRNewswire/ -- United Therapeu...
Harbour BioMed and Dana-Farber Cancer Institute Collaborate to Advance Novel Biotherapies for Cancer Treatment PR Newswire CAMBRIDGE, Mass. and ROTTERDAM, Netherlands and SUZHOU, China , June 15, 2021 /PRNewswire/ -- Harbour BioMed (HKEX: 0...
News, Short Squeeze, Breakout and More Instantly...
Bio-Rad Laboratories Inc. Class A Company Name:
BIO Stock Symbol:
NYSE Market:
Bio-Rad Laboratories, Inc. (NYSE: BIO and BIO.B), a global leader in life science research and clinical diagnostics products, today announced that its Chief Operating Officer Andy Last and Chief Financial Officer Roop K. Lakkaraju will participate in a fireside chat event during the RBC Capital M...
Bio-Rad Laboratories, Inc. (NYSE: BIO and BIO.B), a global leader in life science research and clinical diagnostics products, today announced the promotion of James J. Barry, currently Senior Vice President of Global Manufacturing, to the position of Executive Vice President and President of the ...
Bio-Rad Laboratories, Inc. (NYSE: BIO and BIO.B), a global leader in life science research and clinical diagnostics products, will report its financial results for the first quarter of 2024 on Tuesday, May 7, 2024, following the close of the market. Management will discuss these results in a conf...